1-21570274-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B.

Score: -20 - Benign
-20
-12 -7 -6 -1 0 5 6 9 10 12
BP4_StrongBP6_Very_StrongBA1

The NM_000478.6(ALPL):​c.793-31C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.161 in 1,610,114 control chromosomes in the GnomAD database, including 21,467 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1609 hom., cov: 32)
Exomes 𝑓: 0.16 ( 19858 hom. )

Consequence

ALPL
NM_000478.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.10

Publications

26 publications found
Variant links:
Genes affected
ALPL (HGNC:438): (alkaline phosphatase, biomineralization associated) This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects. [provided by RefSeq, Oct 2015]
ALPL Gene-Disease associations (from GenCC):
  • adult hypophosphatasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
  • childhood hypophosphatasia
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, ClinGen, Orphanet
  • hypophosphatasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, G2P
  • infantile hypophosphatasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • odontohypophosphatasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • perinatal lethal hypophosphatasia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-21570274-C-T is Benign according to our data. Variant chr1-21570274-C-T is described in ClinVar as [Benign]. Clinvar id is 256232.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.176 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALPLNM_000478.6 linkc.793-31C>T intron_variant Intron 7 of 11 ENST00000374840.8 NP_000469.3 P05186-1A0A024RAB4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALPLENST00000374840.8 linkc.793-31C>T intron_variant Intron 7 of 11 1 NM_000478.6 ENSP00000363973.3 P05186-1

Frequencies

GnomAD3 genomes
AF:
0.141
AC:
21420
AN:
152068
Hom.:
1602
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0947
Gnomad AMI
AF:
0.262
Gnomad AMR
AF:
0.148
Gnomad ASJ
AF:
0.224
Gnomad EAS
AF:
0.180
Gnomad SAS
AF:
0.186
Gnomad FIN
AF:
0.106
Gnomad MID
AF:
0.209
Gnomad NFE
AF:
0.160
Gnomad OTH
AF:
0.163
GnomAD2 exomes
AF:
0.162
AC:
40526
AN:
250202
AF XY:
0.166
show subpopulations
Gnomad AFR exome
AF:
0.0970
Gnomad AMR exome
AF:
0.140
Gnomad ASJ exome
AF:
0.233
Gnomad EAS exome
AF:
0.195
Gnomad FIN exome
AF:
0.108
Gnomad NFE exome
AF:
0.164
Gnomad OTH exome
AF:
0.170
GnomAD4 exome
AF:
0.163
AC:
237261
AN:
1457928
Hom.:
19858
Cov.:
31
AF XY:
0.164
AC XY:
119111
AN XY:
725528
show subpopulations
African (AFR)
AF:
0.0965
AC:
3223
AN:
33390
American (AMR)
AF:
0.139
AC:
6220
AN:
44620
Ashkenazi Jewish (ASJ)
AF:
0.220
AC:
5746
AN:
26106
East Asian (EAS)
AF:
0.178
AC:
7077
AN:
39658
South Asian (SAS)
AF:
0.203
AC:
17481
AN:
86116
European-Finnish (FIN)
AF:
0.109
AC:
5788
AN:
53272
Middle Eastern (MID)
AF:
0.205
AC:
1182
AN:
5764
European-Non Finnish (NFE)
AF:
0.163
AC:
180543
AN:
1108734
Other (OTH)
AF:
0.166
AC:
10001
AN:
60268
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
10901
21802
32702
43603
54504
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6432
12864
19296
25728
32160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.141
AC:
21437
AN:
152186
Hom.:
1609
Cov.:
32
AF XY:
0.139
AC XY:
10348
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.0950
AC:
3943
AN:
41520
American (AMR)
AF:
0.148
AC:
2257
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.224
AC:
778
AN:
3470
East Asian (EAS)
AF:
0.180
AC:
930
AN:
5174
South Asian (SAS)
AF:
0.186
AC:
898
AN:
4826
European-Finnish (FIN)
AF:
0.106
AC:
1122
AN:
10596
Middle Eastern (MID)
AF:
0.204
AC:
60
AN:
294
European-Non Finnish (NFE)
AF:
0.160
AC:
10863
AN:
68002
Other (OTH)
AF:
0.165
AC:
348
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
947
1893
2840
3786
4733
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
252
504
756
1008
1260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.161
Hom.:
6518
Bravo
AF:
0.145
Asia WGS
AF:
0.178
AC:
621
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Infantile hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Adult hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Childhood hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.8
DANN
Benign
0.47
PhyloP100
-2.1
PromoterAI
-0.0080
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1256328; hg19: chr1-21896767; API